Volume 31, Issue 1 supplement | Cancer and Metastasis Reviews

Search all Cancer and Metastasis Reviews articles

Volume 31, Issue 1 supplement

September 2012

Supplement Issue: Optimize Project: Recommendations of the currently management in metastatic Renal Cell Carcinoma

Issue Editors:

Daniel Castellano,
Joaquim Bellmunt

6 articles in this issue

The optimize project: beyond first-line therapy in metastatic renal cell carcinoma
Daniel Castellano
Joaquim Bellmunt
EditorialNotes 06 July 2012 Pages: 1 - 2
Evaluation of patients with metastatic renal cell carcinoma after failure of first-line treatment
Joan Carles
Isabel Chirivella
Francisco Xavier García del Muro
ReviewPaper 12 June 2012 Pages: 3 - 9
Sequential therapy in metastatic renal cell carcinoma: pre-clinical and clinical rationale for selecting a second- or subsequent-line therapy with a different mechanism of action
José Luís González Larriba
Enrique Espinosa
Joaquim Bellmunt
ReviewPaper 07 June 2012 Pages: 11 - 17
Management of adverse events of targeted therapies in normal and special patients with metastatic renal cell carcinoma
María José Méndez-Vidal
Esther Martínez Ortega
Ruth Viciana
ReviewPaper 22 July 2012 Pages: 19 - 27
The role of pharmacogenomics in metastatic renal cell carcinoma
Daniel Castellano
Juan Antonio Virizuela
Luís Paz-Ares
ReviewPaper 22 June 2012 Pages: 29 - 32
Quality of life and supportive care for patients with metastatic renal cell carcinoma
Julio Lambea
Carmen Hinojo
Emilio Esteban
ReviewPaper 10 June 2012 Pages: 33 - 39